Humana Inc. (NYSE:HUM) Shares Bought by Cognios Beta Neutral Large Cap Fund LP

Cognios Beta Neutral Large Cap Fund LP lifted its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 14.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,656 shares of the insurance provider’s stock after buying an additional 211 shares during the quarter. Cognios Beta Neutral Large Cap Fund LP’s holdings in Humana were worth $574,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Rakuten Securities Inc. purchased a new stake in Humana during the 4th quarter worth approximately $25,000. Gradient Investments LLC increased its position in shares of Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 40 shares in the last quarter. Cetera Trust Company N.A acquired a new position in Humana in the 4th quarter valued at $28,000. Private Wealth Management Group LLC purchased a new position in Humana in the 4th quarter valued at $32,000. Finally, Carolinas Wealth Consulting LLC boosted its stake in Humana by 274.1% during the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after purchasing an additional 74 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Bank of America increased their target price on shares of Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research report on Monday, May 20th. Truist Financial increased their price objective on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a report on Monday. Oppenheimer lowered their target price on Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Barclays cut their price target on Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $360.00 target price on shares of Humana in a report on Wednesday, June 12th. Fourteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $402.05.

Read Our Latest Report on Humana

Humana Trading Up 3.0 %

NYSE HUM traded up $11.39 on Tuesday, reaching $395.60. The stock had a trading volume of 1,553,529 shares, compared to its average volume of 1,771,052. Humana Inc. has a 12-month low of $298.61 and a 12-month high of $530.54. The stock has a fifty day moving average price of $358.11 and a two-hundred day moving average price of $346.61. The firm has a market capitalization of $47.67 billion, a price-to-earnings ratio of 24.63, a P/E/G ratio of 2.21 and a beta of 0.51. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUMGet Free Report) last posted its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the prior year, the company earned $9.38 EPS. Humana’s revenue was up 10.7% on a year-over-year basis. As a group, sell-side analysts forecast that Humana Inc. will post 16.27 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 0.89%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s payout ratio is 22.04%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.